Automated electronic health record-based screening for Fabry disease in unexplained left ventricular hypertrophy (FAPREV-HCM)
Authors
- Claudia Sommer (ORCID: https://orcid.org/0000-0002-7064-5002)
- Lora Lorenz
- Christoph Wanner (ORCID: https://orcid.org/0000-0001-9507-5301)
- Peter Nordbeck (ORCID: https://orcid.org/0000-0002-2560-4068)
- Nurcan Üçeyler (ORCID: https://orcid.org/0000-0001-6973-6428)
- Kolja Lau (ORCID: https://orcid.org/0000-0002-4317-8824)
- Georg Fette (ORCID: https://orcid.org/0000-0002-0369-3805)
- Victoria Sokalski
Institutions
- Universitätsklinikum Würzburg (DE)
Funders
- Amgen
- Eli Lilly and Company
- AstraZeneca
- Sanofi
- Alexion Pharmaceuticals
- Amicus Therapeutics
- Novo Nordisk
- Idorsia Pharmaceuticals